Last10K.com

Enveric Biosciences, Inc. (ENVB) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2021

Enveric Biosciences, Inc.

CIK: 890821 Ticker: ENVB
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Mar. 30, 2022
Jun. 30, 2021
Cover [Abstract]    
Document Type10-K   
Amendment Flagfalse   
Document Annual Reporttrue   
Document Transition Reportfalse   
Document Period End DateDec. 31, 2021   
Document Fiscal Period FocusFY   
Document Fiscal Year Focus2021   
Current Fiscal Year End Date--12-31   
Entity File Number001-38286   
Entity Registrant NameENVERICBIOSCIENCES, INC.   
Entity Central Index Key0000890821   
Entity Tax Identification Number95-4484725   
Entity Incorporation, State or Country CodeDE   
Entity Address, Address Line One4851 Tamiami Trail N   
Entity Address, Address Line TwoSuite 200   
Entity Address, City or TownNaples   
Entity Address, State or ProvinceFL   
Entity Address, Postal Zip Code34103   
City Area Code(239)   
Local Phone Number302-1707   
Title of 12(b) SecurityCommon Stock, $0.01 par value per share   
Trading SymbolENVB   
Security Exchange NameNASDAQ   
Entity Well-known Seasoned IssuerNo   
Entity Voluntary FilersNo   
Entity Current Reporting StatusYes   
Entity Interactive Data CurrentYes   
Entity Filer CategoryNon-accelerated Filer   
Entity Small Businesstrue   
Entity Emerging Growth Companyfalse   
Entity Shell Companyfalse   
Entity Public Float   $ 51.0
Entity Common Stock, Shares Outstanding  52,585,120 
ICFR Auditor Attestation Flagfalse   
Auditor NameFriedman LLPMarcum LLP  
Auditor Firm ID711688  
Auditor LocationEast Hanover, New JerseyNewYork, NY  

View differences made from one year to another to evaluate Enveric Biosciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Enveric Biosciences, Inc..

Continue

Assess how Enveric Biosciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Enveric Biosciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
M & A
Mgmt Change
Revenue
Other
Filter Subcategory:
All
Shares
Expense
Income
Geography
Cash Flow
Product
Other
Inside Enveric Biosciences, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Shareholders' Equity (Deficit)
Consolidated Statements Of Operations And Comprehensive Loss
Amalgamation With Magicmed Industries Inc.
Amalgamation With Magicmed Industries Inc. (Details Narrative)
Amalgamation With Magicmed Industries Inc. (Tables)
Ameri Tender Agreement
Ameri Tender Agreement (Details Narrative)
Business And Liquidity And Other Uncertainties
Business And Liquidity And Other Uncertainties (Details Narrative)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Commitments And Contingencies (Tables)
Debt
Debt (Details Narrative)
Debt (Tables)
Income Taxes
Income Taxes (Details Narrative)
Income Taxes (Tables)
Intangible Assets And Goodwill
Intangible Assets And Goodwill (Details Narrative)
Intangible Assets And Goodwill (Tables)
Property And Equipment
Property And Equipment (Details Narrative)
Property And Equipment (Tables)
Schedule Of Beneficial Conversion Feature And Warrants (Details)
Schedule Of Black Scholes Valuation Models Of Warrant Liabilities (Details)
Schedule Of Business Acquisitions (Details)
Schedule Of Business Acquisitions (Details) (Parenthetical)
Schedule Of Deferred Tax Assets And Liabilities (Details)
Schedule Of Earning (Loss) Before Income Tax (Details)
Schedule Of Effective Statutory Income Tax Rate (Details)
Schedule Of Fair Value Hierarchy Of Valuation Inputs On Recurring Basis (Details)
Schedule Of Fair Value Of Warrant Liabilities (Details)
Schedule Of Finite Lived Intangible Assets Amortization Expense (Details)
Schedule Of Future Minimum Rental Payment (Details)
Schedule Of Goodwill Indefinite And Finite Lived Intangible Assets (Details)
Schedule Of Income Tax Expense Benefits (Details)
Schedule Of Interest Expense And Amortization Of Debt Discount (Details)
Schedule Of Lease Assets And Liabilities (Details)
Schedule Of Operating Loss Carry Forwards (Details)
Schedule Of Potentially Dilutive Securities (Details)
Schedule Of Proforma Information (Details)
Schedule Of Property Plant And Equipment Net Of Accumulated Depreciation (Details)
Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed (Details)
Schedule Of Restricted Stock Units And Awards Activity (Details)
Schedule Of Stock Option Assumption (Details)
Schedule Of Stock Options (Details)
Schedule Of Warrants (Details)
Schedule Of Weighted Average Remaining Lease Term (Details)
Share Capital And Other Equity Instruments
Share Capital And Other Equity Instruments (Details Narrative)
Share Capital And Other Equity Instruments (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Ticker: ENVB
CIK: 890821
Form Type: 10-K Annual Report
Accession Number: 0001493152-22-008510
Submitted to the SEC: Thu Mar 31 2022 4:43:16 PM EST
Accepted by the SEC: Thu Mar 31 2022
Period: Friday, December 31, 2021
Industry: Semiconductors And Related Devices

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/envb/0001493152-22-008510.htm